Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

H 5486Session 2025-2026

What changed between versions

21 paragraphs changed+101 words added−17 removed

Highlighted text was added in the newer version. Struck-through text was removed.

South Carolina General Assembly 126th Session, 2025-2026

Bill 5486

Download This Bill in Microsoft Word Format

Indicates Matter Stricken Indicates New Matter

(Text matches printed bills. Document has been reformatted to meet World Wide Web specifications.)

H. 5486

STATUS INFORMATION

General Bill Sponsors: Rep. Grant Document Path: LC-0499VR26.docx

Introduced in the House on April 1, 2026 Currently residing in the House Committee on Medical, Military, Public and Municipal Affairs

HISTORY OF LEGISLATIVE ACTIONS

Date

Body

Action Description with journal page number

4/1/2026

House

Introduced and read first time (House Journal-page 8)

4/1/2026

House

Referred to Committee on Medical, Military, Public and Municipal Affairs (House Journal-page 8)

View the latest legislative information at the website

VERSIONS OF THIS BILL

04/01/2026

A bill

7 unchanged paragraphs

TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY ADDING SECTION 44-6-120 SO AS TO REQUIRE THE DEPARTMENT OF HEALTH AND HUMAN SERVICES TO CONDUCT AN ANNUAL REVIEW OF MEDICATIONS AND TREATMENTS FOR CHRONIC AND RARE KIDNEY DISEASES FOR ENROLLEES IN THE SOUTH CAROLINA MEDICAID PROGRAM IN ORDER TO DETERMINE THE ADEQUACY OF THE AVAILABLE TREATMENTS AND TO MAKE RECOMMENDATIONS REGARDING POTENTIAL NEW TREATMENTS; TO REQUIRE THE DEPARTMENT TO PUBLISH AN ANNUAL REPORT; AND FOR OTHER PURPOSES.

Be it enacted by the General Assembly of the State of South Carolina:

SECTION 1. Article 1, Chapter 6, Title 44 of the S.C. Code is amended by adding:

Section 44-6-120. (A) The department shall conduct an annual review of all medications and forms of treatment for chronic and rare kidney diseases, and services for enrollees with a diagnosis of chronic or rare kidney disease, that are eligible for coverage under the South Carolina Medicaid program. The purpose of the annual review is to determine if the available covered medications, treatments, and services are adequate to meet the needs of enrollees with a diagnosis of chronic or rare kidney disease, and whether the department should seek to add additional medications, treatments, or services.

(B) When conducting the annual review required by this section, the department shall solicit and consider input from the public, with specific emphasis on attempting to receive input from persons or groups with knowledge and experience in chronic and rare kidney diseases.

(C) On or before January 15, 2027, and on or before January fifteenth each year thereafter, the department shall submit a report to the clerks of the Senate and the House of Representatives for distribution to the appropriate subject matter committees that details the findings from the annual review required by this section, as well as any recommendations to the General Assembly based upon those findings. The department shall publish the annual report required by this subsection on its website in a manner accessible by the general public.

SECTION 2. This act takes effect upon approval by the Governor.

----XX----

This web page was last updated on April 011, 2026 at 12:07 PM

Back to the full text